Low-dose acetazolamide reverses periventricular white matter hyperintensities in iNPH
Open accessThe DOI matches its Crossref record.
Abstract
OBJECTIVE: To assess the effects of low-dose acetazolamide treatment on volumetric MRI markers and clinical outcome in idiopathic normal-pressure hydrocephalus (iNPH). METHODS: We analyzed MRI and gait measures from 8 patients with iNPH with serial MRIs from an institutional review board-approved imaging protocol who had been treated off-label with low-dose acetazolamide (125-375 mg/day). MRI studies included fluid-attenuated inversion recovery and 3D T1-weighted high-resolution imaging. Automated analyses were employed to quantify each patient's ventricular, global white matter hyperintensities (WMH), and periventricular WMH (PVH) volumes prior to and throughout treatment. Clinical outcome was based on gait changes assessed quantitatively using the Boon scale. RESULTS: Five of 8 patients responded positively to treatment, with median gait improvement of 4 points on the Boon scale. A significant decrease in PVH volume (-6.1 ± 1.9 mL, p = 0.002) was seen in these patients following treatment. One patient's gait was unchanged and 2 patients demonstrated worsened gait and were referred for shunt surgery. No reduction in PVH volume was detected in the latter 2 patients. Nonperiventricular WMH and lateral ventricle volumes remained largely unchanged in all patients. CONCLUSIONS: These preliminary findings provide new evidence that low-dose acetazolamide can reduce PVH and may improve gait in iNPH. PVH volume, reflecting transependymal CSF, is shown to be a potential MRI indicator of pharmacologic intervention effectiveness. Further studies of pharmacologic treatment of iNPH are needed and may be enhanced by incorporating quantitative MRI outcomes. CLASSIFICATION OF EVIDENCE: This study provides Class IV evidence that low-dose acetazolamide reverses PVH volume and, in some cases, improves gait in iNPH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Bakker, E. N. T. P., Bacskai, B. J., Arbel-Ornath, M., Aldea, R., Bedussi, B., Morris, A. W. J., Weller, R. O., & Carare, R. O. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0273-8 · Cited by 353
Diagnosis and Treatment of Idiopathic Normal Pressure Hydrocephalus
Williams, M. A., & Malm, J. (2016) · Continuum · doi:10.1212/con.0000000000000305 · Cited by 272
Eide, P. K., & Hansson, H. ‐. (2018) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12420 · Cited by 119
Carbonic anhydrase inhibition selectively prevents amyloid β neurovascular mitochondrial toxicity
Solesio, M. E., Peixoto, P. M., Debure, L., Madamba, S. M., de Leon, M. J., Wisniewski, T., Pavlov, E. V., & Fossati, S. (2018) · Aging Cell · doi:10.1111/acel.12787 · Cited by 92
Spaceflight-induced changes in white matter hyperintensity burden in astronauts
Alperin, N., Bagci, A. M., & Lee, S. H. (2017) · Neurology · doi:10.1212/wnl.0000000000004475 · Cited by 73
Self-citation
Metadata
- Authors
- Alperin, N., Oliu, C. J., Bagci, A. M., Lee, S. H., Kovanlikaya, I., Adams, D., Katzen, H., Ivkovic, M., Heier, L., & Relkin, N.
- Venue
- Neurology
- Published
- 2014-04-15
- Volume
- 82
- Issue
- 15
- Pages
- 1347-1351
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2150802909
- Cited by
- 76
- References
- 0
- FWCI
- 3.09
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Low-dose acetazolamide reverses periventricular white matter hyperintensities in iNPH. https://app.cochat.ai/papers/10.1212/wnl.0000000000000313
- The paper
- Alperin, N., Oliu, C. J., Bagci, A. M., Lee, S. H., Kovanlikaya, I., Adams, D., Katzen, H., Ivkovic, M., Heier, L., & Relkin, N. (2014). Low-dose acetazolamide reverses periventricular white matter hyperintensities in iNPH. Neurology. https://doi.org/10.1212/wnl.0000000000000313
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.